enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

robot
Abstract generation in progress

enVVeno Medical Corporation announced it has regained compliance with Nasdaq’s minimum bid price requirement of $1.00 per share. The company’s common stock maintained a closing bid price at or above $1.00 for 10 consecutive business days, leading Nasdaq to close the matter. With approximately $28 million in cash and investments as of December 31, 2025, enVVeno Medical is well-positioned for its 2026 strategic plans.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin